These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Primary tuberculosis of glans penis after intravesical Bacillus Calmette Guerin immunotherapy. Sharma VK; Sethy PK; Dogra PN; Singh U; Das P Indian J Dermatol Venereol Leprol; 2011; 77(1):47-50. PubMed ID: 21220879 [TBL] [Abstract][Full Text] [Related]
48. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer. Guerra CE; Betts RF; O'Keefe RJ; Shilling JW Clin Infect Dis; 1998 Sep; 27(3):639-40. PubMed ID: 9770167 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells. Ratliff TL; Shapiro A; Catalona WJ Clin Immunol Immunopathol; 1986 Oct; 41(1):108-15. PubMed ID: 3527506 [TBL] [Abstract][Full Text] [Related]
50. [Saccharomyces-induced hypersensitivity pneumonitis in a dairy farmer: a case report]. Yamamoto Y; Osanai S; Fujiuchi S; Akiba Y; Honda H; Nakano H; Ohsaki Y; Kikuchi K Nihon Kokyuki Gakkai Zasshi; 2002 Jun; 40(6):484-8. PubMed ID: 12325333 [TBL] [Abstract][Full Text] [Related]
51. Non-specific immunotherapy with bacille Calmette-Guérin (BCG). van der Meijden AP Clin Exp Immunol; 2001 Feb; 123(2):179-80. PubMed ID: 11252346 [No Abstract] [Full Text] [Related]
52. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. Kavoussi LR; Brown EJ; Ritchey JK; Ratliff TL J Clin Invest; 1990 Jan; 85(1):62-7. PubMed ID: 2404029 [TBL] [Abstract][Full Text] [Related]
53. [Sepsis syndrome and bone marrow granulomatosis after intravesical instillation of BCG]. Andrès E; Kuhnert C; Perrin AE; Averous G; Ruellan A; Goichot B; Schlienger JL Presse Med; 1999 Oct; 28(32):1753-4. PubMed ID: 10566276 [TBL] [Abstract][Full Text] [Related]
54. Systemic hypersensitivity reaction to intravesical BCG. Lyons D; Miller I; Jeffers A Scott Med J; 1994 Apr; 39(2):49-50. PubMed ID: 8720760 [TBL] [Abstract][Full Text] [Related]
55. New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: A case study. Davalos L; Kushlaf H Muscle Nerve; 2019 Jan; 59(1):E1-E2. PubMed ID: 30144311 [No Abstract] [Full Text] [Related]
56. Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer. Stassar MJ; Vegt PD; Steerenberg PA; van der Meijden AP; Meiring HD; Dessens-Kroon M; Geertzen HG; den Otter W Urol Res; 1994; 22(3):177-84. PubMed ID: 7992464 [TBL] [Abstract][Full Text] [Related]
57. [BCG infection following intravesicular immunotherapy for bladder cancer]. Levi L; Groh M; De Castro N; Bergeron A; Schlemmer F Rev Mal Respir; 2018 Apr; 35(4):416-429. PubMed ID: 29754838 [TBL] [Abstract][Full Text] [Related]
58. [Clinical characteristic analysis of 96 cases of hypersensitivity pneumonitis]. Jin BB; Xu WB; Peng M; Shi JH; Tian XL; Liu YJ; Feng RE; Liu HR; Cai BQ; Shao C; Huang H; Liu T; Zhang H Zhonghua Jie He He Hu Xi Za Zhi; 2013 Feb; 36(2):83-7. PubMed ID: 23537550 [TBL] [Abstract][Full Text] [Related]
59. [Unusual evolution of reactive arthritis after endovesical immunotherapy with BCG]. Hernández Fernández A; Pinilla-Gracia C; Rodríguez Nogué L; Panisello Sebastiá JJ; Martínez Delgado F An Sist Sanit Navar; 2020 Aug; 43(2):267-271. PubMed ID: 32814932 [TBL] [Abstract][Full Text] [Related]